Metraipolis › archive › dc_ce56eda61127

Neuromuscular electrical stimulation for physical function maintenance during hematopoietic stem cell transplantation: Study protocol — Europe PMC PMID:38728244

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38728244
DOI
10.1371/journal.pone.0302970
License (as archived)
CC0-1.0
Archived
2026-10-06T18:31:43.251Z
SHA-256 of the archived text
15589ad9e3c3167bc7b762ea72540e9a8beb1e9190b6b1a6c38ccf17721bedb2
Stable URL of this page
https://metraipolis.com/documento/dc_ce56eda61127

How to cite

Neuromuscular electrical stimulation for physical function maintenance during hematopoietic stem cell transplantation: Study protocol — Europe PMC PMID:38728244 — Europe PMC (en), https://europepmc.org/article/MED/38728244 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_ce56eda61127 (Metraipolis archive dc_ce56eda61127, sha256 15589ad9e3c3167bc7b762ea72540e9a8beb1e9190b6b1a6c38ccf17721bedb2)
BibTeX
@misc{dcce56eda61127,
  title = {Neuromuscular electrical stimulation for physical function maintenance during hematopoietic stem cell transplantation: Study protocol — Europe PMC PMID:38728244},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38728244},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_ce56eda61127; sha256 15589ad9e3c3167bc7b762ea72540e9a8beb1e9190b6b1a6c38ccf17721bedb2},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38728244. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Hematopoietic stem cell transplantation is a common life-saving treatment for hematologic malignancies, though can lead to long-term functional impairment, fatigue, muscle atrophy, with decreased quality of life. Although traditional exercise has helped reduce these effects, it is inconsistently recommended and infrequently maintained, and most patients remain sedentary during and after treatment. There is need for alternative rehabilitation strategies, like neuromuscular electrical stimulation, that may be more amenable to the capabilities of hematopoietic stem cell transplant recipients. Patients receiving autologous HCT are being enroled in a randomized controlled trial with 1:1 (neuromuscular electrical stimulation:sham) design stratified by diagnosis and sex. Physical function, body composition, quality of life, and fatigue are assessed prior to hematopoietic stem cell transplant (prior to initiating preparatory treatment) and 24±5 days post hematopoietic stem cell transplant (Follow-up 1); physical function and quality of life are also assessed 6-months post hematopoietic stem cell transplant (Follow-up 2). The primary outcome is between-group difference in the 6-minute walk test change scores (Follow-up 1-Pre-transplant; final enrolment goal N = 23/group). We hypothesize that 1) neuromuscular electrical stimulation will attenuate hematopoietic stem cell transplant-induced adverse effects on physical function, muscle mass, quality of life, and fatigue compared to sham at Follow-up 1, and 2) Pre-transplant physical function will significantly predict fatigue and quality of life at Follow-up 2. We will also describe feasibility and acceptability of neuromuscular electrical stimulation during hematopoietic stem cell transplant. This proposal will improve rehabilitative patient care and quality of life by determining efficacy and feasibility of a currently underutilized therapeutic strategy aimed at maintaining daily function and reducing the impact of a potent and widely used cancer treatment. This trial is registered with clinicaltrials.gov (NCT04364256).

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2024 (prima pubblicazione 2024-05-10).
Identificativi: PMID 38728244 · PMCID PMC11086915 · DOI 10.1371/journal.pone.0302970.
Descrittori MeSH principali: Electric Stimulation Therapy; Hematopoietic Stem Cell Transplantation; Quality of Life.
Pagina: https://europepmc.org/article/MED/38728244 — https://doi.org/10.1371/journal.pone.0302970. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T16:55:36.224Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.